Why Cannabis Stock HEXO Has a Bright Future
Marijuana Paraphernalia Companies Are Taking a Hit From Tariffs
Aurora Cannabis Lost Money in Q3 — And That’s Okay?
JPMorgan Expands Into Healthcare Payments, to Buy InstaMed
Collision Conference 2019
These Billionaire Money Managers Bought Aurora Cannabis Stock in the First Quarter
Up More Than 100% Already, It’s Time to Take Profits on Hexo Stock
Tilray Fell More after Its Earnings Last Week
Tilray CEO Says Some Cannabis Companies Misled Investors
If You Had Bought HEXO (TSE:HEXO) Stock A Year Ago, You Could Pocket A 81% Gain Today
CURE Pharmaceutical Expands Leadership Team with Key New Hires
Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility
Village Farms International Announces Pure Sunfarms' Receipt of Standard Processing License for its Delta 3 Greenhouse Facility
Intec Pharma Granted European Patent
Investing $1,000 in HEXO, OrganiGram, and Aleafia 2 Years Ago Is Worth This Much Today
Investors keep food firms on warning over antibiotics
The Solar (WSE:SOL) Share Price Is Down 80% So Some Shareholders Are Rather Upset
Is Now The Time To Put Maxcom (WSE:MXC) On Your Watchlist?
Aurora Cannabis Had a Great Quarter -- but Here's What We Still Don't Know
3 Big-Name Pot Stocks Money Managers Dumped in the First Quarter
How Did Tilray Stack Up to the Competition?
Aurora Makes Its Case to Be Pot's Dominant Player
Marijuana Companies Lied to You, Major Pot CEO Alleges
A Top U.S. Pension Loads Up on Alibaba, Cronos, and Zillow Stock, Sells PG&E
Top Analyst Weighs in on Canopy Growth and Cronos Group
A look at efforts to make legal pot foster social justice
Pot in focus for some Calgary event organizers as summer looms
3 Brand-Name Food and Beverage Companies That Want In on the Marijuana Craze
The Week In Cannabis: Big Earnings Reports, Biden's Change Of Heart, New Report On Dispensaries
Better Buy: Aphria vs. Aurora Cannabis
Everybody Hates New Age Beverages Stock
You'll Never Guess Who's Betting Against Canadian Cannabis Stocks
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs